STAT3 and cancer: While a systemically stable cyclic STAT3 decoy has been shown to have an anti-cancer effect after intravenous injection, the opportunity to increase concentrations of the STAT3 decoy to the tumor region using targeted delivery approaches remains relatively unexplored [14].